Inventiva S.A. Sponsored ADR (IVA) vs Oric Pharmaceuticals, Inc. (ORIC)

Inventiva S.A. Sponsored ADR and Oric Pharmaceuticals, Inc. are both Biotechnology companies. Inventiva S.A. Sponsored ADR and Oric Pharmaceuticals, Inc. are of similar size ($880.0M and $867.9M). Oric Pharmaceuticals, Inc. has the higher net margin (0.00% vs −750.3%) and the lower return on invested capital (−83.8% vs 0.00%). Across the 11 metrics below, Inventiva S.A. Sponsored ADR leads on 6 and Oric Pharmaceuticals, Inc. on 5.

Valuation

Metric IVA ORIC Biotechnology median
P/E n/m n/m 10.60
P/S 7.43 n/m 9.40
P/B 2.13 2.49 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 1.54 n/m 9.02
Earnings yield (94.51%) (15.34%) (32.88%)
Free cash flow yield (94.32%) (11.81%) (23.13%)

Profitability

Metric IVA ORIC Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin (750.28%) 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (39.80%) (51.96%)
Return on assets 0.00% (37.35%) (46.06%)
Return on invested capital 0.00% (83.77%) 0.00%

Growth

Metric IVA ORIC Biotechnology median
Revenue growth (TTM) 547.89% — 6.76%
EPS growth (last fiscal year) 35.44% 19.67% 29.88%
Revenue growth, 5-year CAGR 8.33% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IVA ORIC Biotechnology median
Debt to equity 1.13 0.00 0.00
Current ratio 3.81 13.19 4.97
Net debt to EBITDA 0.29 1.95 1.01

Dividend

Metric IVA ORIC Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric IVA ORIC Biotechnology median
Market cap 867.93m 880.01m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack